Jeremias A - Search Results

1

Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L. Parikh PB, et al. Among authors: jeremias a. J Invasive Cardiol. 2013 Mar;25(3):114-7. J Invasive Cardiol. 2013. PMID: 23468438 Free article.

2

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency.

Jeremias A, Bhatt DL, Chew DP, Ziada KM, Albirini A, Brener SJ, Lincoff AM, Topol EJ, Ellis SG. Jeremias A, et al. Am J Cardiol. 2002 May 15;89(10):1209-11. doi: 10.1016/s0002-9149(02)02308-1. Am J Cardiol. 2002. PMID: 12008179 No abstract available.

3

Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.

Jeremias A, Albirini A, Ziada KM, Chew DP, Brener SJ, Topol EJ, Ellis SG. Jeremias A, et al. Am Heart J. 2002 Jun;143(6):1040-5. doi: 10.1067/mhj.2002.122124. Am Heart J. 2002. PMID: 12075261

4

Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention.

Jeremias A, Kirtane A. Jeremias A, et al. Ann Intern Med. 2008 Feb 5;148(3):234-8. doi: 10.7326/0003-4819-148-3-200802050-00199. Epub 2007 Dec 17. Ann Intern Med. 2008. PMID: 18087049 Free article. Review.

5

Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.

Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KK, Cutlip DE, Carrozza JP Jr, Cohen DJ. Jeremias A, et al. Coron Artery Dis. 2008 Mar;19(2):111-5. doi: 10.1097/MCA.0b013e3282f34220. Coron Artery Dis. 2008. PMID: 18300748

6

Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.

Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ; Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Jeremias A, et al. Circulation. 2008 Aug 5;118(6):632-8. doi: 10.1161/CIRCULATIONAHA.107.752428. Epub 2008 Jul 21. Circulation. 2008. PMID: 18645057

7

The impact of revascularization on mortality in patients with nonacute coronary artery disease.

Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. Jeremias A, et al. Am J Med. 2009 Feb;122(2):152-61. doi: 10.1016/j.amjmed.2008.07.027. Am J Med. 2009. PMID: 19185092

8

Provisional use of glycoprotein IIb/IIIa inhibitors in the era of dual antiplatelet therapy--do "bailouts" pay off?

Jeremias A, Gruberg L. Jeremias A, et al. J Invasive Cardiol. 2009 Jun;21(6):264-5. J Invasive Cardiol. 2009. PMID: 19494401 No abstract available.

9

A mechanical approach to limit contrast-induced nephropathy: sentinel at the gate.

Gruberg L, Jeremias A. Gruberg L, et al. Among authors: jeremias a. J Invasive Cardiol. 2009 Jul;21(7):319-20. J Invasive Cardiol. 2009. PMID: 19571340 No abstract available.

10

Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting.

Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL. Jeremias A, et al. Catheter Cardiovasc Interv. 2010 May 1;75(6):895-902. doi: 10.1002/ccd.22349. Catheter Cardiovasc Interv. 2010. PMID: 20088008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters